IKARE Ltd (pronounced "I care") is a UK registered charity applying venture philanthropic principles to the causes it supports. IKARE aims to overlay private equity investment techniques and other business expertise and practices into these causes or "investees", thereby contributing more than just funding.

 

Since its inception in 2006, IKARE’s resources have been fully dedicated to the SOS campaign, launched in Kampala, Uganda, in October of the same year. Working together with universities across Edinburgh, the UK and Makerere, Uganda, as well as with the international veterinary pharmaceutical company Ceva Santé Animale, headquartered in France, the SOS campaign aims to control sleeping sickness in Uganda, the only country to be affected by both forms of this lethal disease spread by the tse-tse fly which kills more than 100 people every day in Africa.

 

In addition to providing emergency treatment to around 220,000 cattle in five districts in Northern Uganda, IKARE and its partners are focused on building a sustainable defence to the disease, through educating and teaching both local farmers and key stakeholders on sleeping sickness and the links between animal health and human health, as well as ensuring the availability and affordability of treatments, allowing farmers to treat their cattle on a regular basis.

 

IK Investment Partners has been IKARE's main donor since 2006, providing both financial and non-financial support